THC1 Stock Chart & Stats
€228.00
€25.00(14.62%)
At close: 4:00 PM EDT
€228.00
€25.00(14.62%)
Day’s Range― - ―
52-Week Range€132.00 - €242.00
Previous CloseN/A
Volume187.00
Average Volume (3M)5.00
Market Cap
€18.35B
Enterprise Value€30.83K
Total Cash (Recent Filing)€2.17B
Total Debt (Recent Filing)€13.25B
Price to Earnings (P/E)9.9
Beta0.44
Next Earnings
Nov 03, 2026EPS Estimate
4.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)26.12
Shares Outstanding80,519,000
10 Day Avg. Volume2
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)4.25
Price to Sales (P/S)0.84
P/FCF Ratio7.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€244.57Price Target Upside7.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)18.02
Revenue Forecast (FY)€19.05B
Bulls Say, Bears Say
Bulls Say
Raised Outlook And Operating MomentumThe higher 2026 revenue and EBITDA outlook, supported by reported fundamental outperformance, indicates operating gains are translating into stronger expected earnings power. This improves visibility across the next several quarters and supports continued investment in the company’s hospital and outpatient platforms.
USPI Outpatient Platform StrengthUSPI combines strong profitability with growth in higher-acuity ambulatory procedures, reinforcing Tenet’s position in the structural shift toward outpatient care. Physician alignment and procedure migration can support attractive volumes, pricing per case, and durable segment earnings.
Strong Cash GenerationSubstantial operating and free cash flow gives Tenet internal funding for debt reduction, acquisitions, capital investment, and other strategic priorities. Although cash conversion is not perfect, the scale of generation provides meaningful financial flexibility across the medium-term planning horizon.
Bears Say
Elevated LeverageTenet’s sizable debt burden remains a durable constraint despite improving equity and a better trajectory. Leverage increases exposure to interest costs and refinancing requirements, while also limiting the cash available for acquisitions, investment, and shareholder returns during weaker operating periods.
Exchange Enrollment PressureThe decline in exchange enrollment and revenue creates a continuing payer-mix headwind, particularly in several states where the impact is concentrated. If enrollment remains weak, lower admissions and reimbursement quality could pressure hospital revenue growth and require sustained site-level cost actions.
Earnings And Cash-flow VolatilityWide historical swings in margins and recent free-cash-flow contraction show that reported profitability can vary materially with operating conditions and timing items. This makes medium-term earnings quality less predictable and complicates capital allocation even when current results are strong.
Tenet Healthcare News
THC1 FAQ
What was Tenet Healthcare’s price range in the past 12 months?
Tenet Healthcare lowest stock price was €132.00 and its highest was €242.00 in the past 12 months.
What is Tenet Healthcare’s market cap?
Tenet Healthcare’s market cap is €18.35B.
When is Tenet Healthcare’s upcoming earnings report date?
Tenet Healthcare’s upcoming earnings report date is Nov 03, 2026 which is in 55 days.
How were Tenet Healthcare’s earnings last quarter?
Tenet Healthcare released its earnings results on Jul 23, 2026. The company reported €5.253 earnings per share for the quarter, beating the consensus estimate of €3.657 by €1.596.
Is Tenet Healthcare overvalued?
According to Wall Street analysts Tenet Healthcare’s price is currently Undervalued.
Does Tenet Healthcare pay dividends?
Tenet Healthcare does not currently pay dividends.
What is Tenet Healthcare’s EPS estimate?
Tenet Healthcare’s EPS estimate is 4.01.
How many shares outstanding does Tenet Healthcare have?
Tenet Healthcare has 80,519,000 shares outstanding.
What happened to Tenet Healthcare’s price movement after its last earnings report?
Tenet Healthcare reported an EPS of €5.253 in its last earnings report, beating expectations of €3.657. Following the earnings report the stock price went up 14.62%.
Which hedge fund is a major shareholder of Tenet Healthcare?
Currently, no hedge funds are holding shares in DE:THC1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tenet Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€244.57 (7.27% Upside)
€244.57 (7.27% Upside)
Blogger Sentiment
Bullish
DE:THC1 Sentiment 92%
Sector Average 60%
Sector Average 60%
Insider Transactions
Sold Shares
Worth €38.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.59%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.89%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tenet Healthcare
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
THC1 Company Deck
THC1 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational and financial outperformance: strong revenue and EBITDA growth, a robust EPS increase, raised full-year guidance, substantial free cash flow, improved leverage and active capital deployment (notably large share repurchases and anticipated USPI M&A). These positives were offset by material payer mix challenges—chiefly a significant decline in exchange enrollment and revenues, localized state impacts, modest ASC case volume weakness, and regulatory/reimbursement uncertainty. Management emphasized that expense actions, technology and clinical improvements and portfolio positioning have thus far mitigated the headwinds and supported an upward revision to guidance.View all DE:THC1 earnings summariesTHC1 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€244.57
▲(7.27% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Community Health
―
HCA Healthcare
―
Universal Health
―
Surgery Partners
―
Ardent Health Partners, Inc.
―










